News

Stay updated and learn about the topic of personalized medicine. Comment and share freely. In addition, let us know if you wish us to dig deeper into any new subject.
Mayo Clinic and CurifyLabs study in Pharmaceutics shows 3D-printed low-dose metoprolol tablets met USP limits where manual tablet splitting failed.

Featured Post

Mayo Clinic and CurifyLabs study in Pharmaceutics shows 3D-printed low-dose metoprolol tablets met USP limits where manual tablet splitting failed.

publications

For decades, hospital pharmacies have relied on a simple workaround when commercial low-dose formulations don't exist: split the tablet. Halve it. Quarter it. Give the patient what they need. It's a practice so common that few stop to ask whether it actually delivers the dose on the label.

Read More

Topics

Mayo Clinic and CurifyLabs study in Pharmaceutics shows 3D-printed low-dose metoprolol tablets met USP limits where manual tablet splitting failed.

Mayo Clinic and CurifyLabs study in Pharmaceutics shows 3D-printed low-dose metoprolol tablets met USP limits where manual tablet splitting failed.
publications
Read More